PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

Authors :: Hanwen Zhang
Shuhua Wang
Manali Rupji
Chenxi Wu
Sanjay Chandrasekaran
Christopher R. Funk
Patrick J. King
Saketh Kollipara
Ishani Rao
Esohe Ayanru
Julia Duffy
Roberta Kaplow
Aseala Abousaud
Aneesh Mehta
John D. Roback
Daniel Kalman
G. Marshall Lyon
Mark Caridi-Scheible
Gregory Bisson
Yuan Liu
Silvia Coma
Jonathan A. Pachter
Cynthia R. Giver
Edmund K. Waller
Source :: Blood. 140:11187-11189
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools